Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott R Plotkin

Showing results (61-70 of 201) with videos related to

Pageof 21
Sort By:
Journal of Neuro-Oncology|May 4, 2019
First report of quality of life in adults with neurofibromatosis 2 who are deafened or have significant hearing loss: results of a live-video randomized control trialChristopher J Funes, Ryan A Mace, Erik A Macklin, et al.
Case Reports in Oncology|November 1, 2021
Pseudoprogression of Malignant Peripheral Nerve Sheath Tumor in Patient with Neurofibromatosis Type 1, a Case ReportAndrés J Lessing, Gregory M Cote, Thomas F DeLaney, et al.
The Journal of Biological Chemistry|December 4, 2020
mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibitionRoberta L Beauchamp, Serkan Erdin, Luke Witt, et al.
Medrxiv : the Preprint Server for Health Sciences|June 29, 2026
Development and Initial Validation of the Quality of life Evaluation in <i>NF2</i> -related Schwannomatosis Trials (QUEST) AssessmentVanessa L Merker, Sophia C Carias, Rosalie E Ferner, et al.
Neurosurgery|October 1, 2008
Three-dimensional volumetrics for tracking vestibular schwannoma growth in neurofibromatosis type IIGordon J Harris, Scott R Plotkin, Mia Maccollin, et al.
Familial Cancer|January 30, 2026
Hearing preservation and restoration surgery in NF2-related schwannomatosisChristopher G Wood, Nathan Huey, Christine Carter, et al.
American Journal of Obstetrics and Gynecology|February 18, 2015
Pregnancy complications in women with rare tumor suppressor syndromes affecting central and peripheral nervous systemAnna R Terry, Vanessa L Merker, Fred G Barker, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|July 19, 2012
Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patientsScott R Plotkin, Vanessa L Merker, Chris Halpin, et al.
American Journal of Medical Genetics. Part A|May 31, 2022
Genetic testing to gain diagnostic clarity in neurofibromatosis type 2 and schwannomatosisRebecca Burns, Kristin Niendorf, Kathleen Steinberg, et al.
Orphanet Journal of Rare Diseases|February 11, 2022
Awareness and agreement with neurofibromatosis care guidelines among U.S. neurofibromatosis specialistsVanessa L Merker, Pamela Knight, Heather B Radtke, et al.
Pageof 21

Showing results (61-70 of 201) with videos related to

Sort By:
Pageof 21
Journal of Neuro-Oncology|May 4, 2019
First report of quality of life in adults with neurofibromatosis 2 who are deafened or have significant hearing loss: results of a live-video randomized control trialChristopher J Funes, Ryan A Mace, Erik A Macklin, et al.
Case Reports in Oncology|November 1, 2021
Pseudoprogression of Malignant Peripheral Nerve Sheath Tumor in Patient with Neurofibromatosis Type 1, a Case ReportAndrés J Lessing, Gregory M Cote, Thomas F DeLaney, et al.
The Journal of Biological Chemistry|December 4, 2020
mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibitionRoberta L Beauchamp, Serkan Erdin, Luke Witt, et al.
Medrxiv : the Preprint Server for Health Sciences|June 29, 2026
Development and Initial Validation of the Quality of life Evaluation in <i>NF2</i> -related Schwannomatosis Trials (QUEST) AssessmentVanessa L Merker, Sophia C Carias, Rosalie E Ferner, et al.
Neurosurgery|October 1, 2008
Three-dimensional volumetrics for tracking vestibular schwannoma growth in neurofibromatosis type IIGordon J Harris, Scott R Plotkin, Mia Maccollin, et al.
Familial Cancer|January 30, 2026
Hearing preservation and restoration surgery in NF2-related schwannomatosisChristopher G Wood, Nathan Huey, Christine Carter, et al.
American Journal of Obstetrics and Gynecology|February 18, 2015
Pregnancy complications in women with rare tumor suppressor syndromes affecting central and peripheral nervous systemAnna R Terry, Vanessa L Merker, Fred G Barker, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|July 19, 2012
Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patientsScott R Plotkin, Vanessa L Merker, Chris Halpin, et al.
American Journal of Medical Genetics. Part A|May 31, 2022
Genetic testing to gain diagnostic clarity in neurofibromatosis type 2 and schwannomatosisRebecca Burns, Kristin Niendorf, Kathleen Steinberg, et al.
Orphanet Journal of Rare Diseases|February 11, 2022
Awareness and agreement with neurofibromatosis care guidelines among U.S. neurofibromatosis specialistsVanessa L Merker, Pamela Knight, Heather B Radtke, et al.
Pageof 21